Depressive symptoms in adults with spina bifida

Brad E. Dicianno, Nicholas Kinback, Melissa H. Bellin, Laurie Chaikind, Alhaji M. Buhari, Grayson N. Holmbeck, T. Andrew Zabel, Robert M. Donlan, Diane M. Collins

Research output: Research - peer-reviewArticle

Abstract

Objective: To examine the prevalence of depressive symptoms in adults with spina bifida and identify contributing factors for depressive symptomatology. Method: Retrospective Cohort Study. Data collection was conducted at a regional adult spina bifida clinic. A total of 190 charts from adult patients with spina bifida were included. The main outcome measures were the Beck Depression Inventory-II (BDI-II) and the mobility domain of the Craig Handicap Assessment Reporting Technique-Short Form (CHARTSF). Results: Of the 190 participants, 49 (25.8%) had BDI-II scores (14+) indicative of depressive symptomatology. Sixty-nine (36.3%) were on antidepressants to treat depressive symptoms, and 31 (63.3%) of those with clinical symptoms of depression were on antidepressants. Participants with a history of depressive symptoms may be as high as 45.7% if both participants with BDI-II scores 14+ and those with antidepressant use specifically for the purposes of depression treatment are combined. In this population, lower CHART-SF mobility score, expressing "emotional concerns" as a reason for the visit on an intake sheet, and use of antidepressant medications were significantly associated with depressive symptoms. Conclusions: Depressive symptomatology appears to be common and undertreated in this cohort of adults with spina bifida, which may warrant screening for emotional concerns in routine clinic appointments. Significant depressive symptoms are associated with fewer hours out of bed and fewer days leaving the house. Additional research is needed to assess the impact of interventions directed toward mobility on depression and in the treatment of depression in this patient population.

LanguageEnglish (US)
Pages246-253
Number of pages8
JournalRehabilitation Psychology
Volume60
Issue number3
DOIs
StatePublished - Aug 1 2015

Fingerprint

Spinal Dysraphism
Depression
Antidepressive Agents
Equipment and Supplies
Population
Therapeutics
Appointments and Schedules
Cohort Studies
Retrospective Studies
Outcome Assessment (Health Care)
Research

Keywords

  • Adult
  • Depression
  • Mobility
  • Rehabilitation
  • Spina bifida

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation

Cite this

Dicianno, B. E., Kinback, N., Bellin, M. H., Chaikind, L., Buhari, A. M., Holmbeck, G. N., ... Collins, D. M. (2015). Depressive symptoms in adults with spina bifida. Rehabilitation Psychology, 60(3), 246-253. DOI: 10.1037/rep0000044

Depressive symptoms in adults with spina bifida. / Dicianno, Brad E.; Kinback, Nicholas; Bellin, Melissa H.; Chaikind, Laurie; Buhari, Alhaji M.; Holmbeck, Grayson N.; Andrew Zabel, T.; Donlan, Robert M.; Collins, Diane M.

In: Rehabilitation Psychology, Vol. 60, No. 3, 01.08.2015, p. 246-253.

Research output: Research - peer-reviewArticle

Dicianno, BE, Kinback, N, Bellin, MH, Chaikind, L, Buhari, AM, Holmbeck, GN, Andrew Zabel, T, Donlan, RM & Collins, DM 2015, 'Depressive symptoms in adults with spina bifida' Rehabilitation Psychology, vol 60, no. 3, pp. 246-253. DOI: 10.1037/rep0000044
Dicianno BE, Kinback N, Bellin MH, Chaikind L, Buhari AM, Holmbeck GN et al. Depressive symptoms in adults with spina bifida. Rehabilitation Psychology. 2015 Aug 1;60(3):246-253. Available from, DOI: 10.1037/rep0000044
Dicianno, Brad E. ; Kinback, Nicholas ; Bellin, Melissa H. ; Chaikind, Laurie ; Buhari, Alhaji M. ; Holmbeck, Grayson N. ; Andrew Zabel, T. ; Donlan, Robert M. ; Collins, Diane M./ Depressive symptoms in adults with spina bifida. In: Rehabilitation Psychology. 2015 ; Vol. 60, No. 3. pp. 246-253
@article{bf74215eae4a43be839f500dcfe0d80b,
title = "Depressive symptoms in adults with spina bifida",
abstract = "Objective: To examine the prevalence of depressive symptoms in adults with spina bifida and identify contributing factors for depressive symptomatology. Method: Retrospective Cohort Study. Data collection was conducted at a regional adult spina bifida clinic. A total of 190 charts from adult patients with spina bifida were included. The main outcome measures were the Beck Depression Inventory-II (BDI-II) and the mobility domain of the Craig Handicap Assessment Reporting Technique-Short Form (CHARTSF). Results: Of the 190 participants, 49 (25.8%) had BDI-II scores (14+) indicative of depressive symptomatology. Sixty-nine (36.3%) were on antidepressants to treat depressive symptoms, and 31 (63.3%) of those with clinical symptoms of depression were on antidepressants. Participants with a history of depressive symptoms may be as high as 45.7% if both participants with BDI-II scores 14+ and those with antidepressant use specifically for the purposes of depression treatment are combined. In this population, lower CHART-SF mobility score, expressing {"}emotional concerns{"} as a reason for the visit on an intake sheet, and use of antidepressant medications were significantly associated with depressive symptoms. Conclusions: Depressive symptomatology appears to be common and undertreated in this cohort of adults with spina bifida, which may warrant screening for emotional concerns in routine clinic appointments. Significant depressive symptoms are associated with fewer hours out of bed and fewer days leaving the house. Additional research is needed to assess the impact of interventions directed toward mobility on depression and in the treatment of depression in this patient population.",
keywords = "Adult, Depression, Mobility, Rehabilitation, Spina bifida",
author = "Dicianno, {Brad E.} and Nicholas Kinback and Bellin, {Melissa H.} and Laurie Chaikind and Buhari, {Alhaji M.} and Holmbeck, {Grayson N.} and {Andrew Zabel}, T. and Donlan, {Robert M.} and Collins, {Diane M.}",
year = "2015",
month = "8",
doi = "10.1037/rep0000044",
volume = "60",
pages = "246--253",
journal = "Rehabilitation Psychology",
issn = "0090-5550",
publisher = "American Psychological Association Inc.",
number = "3",

}

TY - JOUR

T1 - Depressive symptoms in adults with spina bifida

AU - Dicianno,Brad E.

AU - Kinback,Nicholas

AU - Bellin,Melissa H.

AU - Chaikind,Laurie

AU - Buhari,Alhaji M.

AU - Holmbeck,Grayson N.

AU - Andrew Zabel,T.

AU - Donlan,Robert M.

AU - Collins,Diane M.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Objective: To examine the prevalence of depressive symptoms in adults with spina bifida and identify contributing factors for depressive symptomatology. Method: Retrospective Cohort Study. Data collection was conducted at a regional adult spina bifida clinic. A total of 190 charts from adult patients with spina bifida were included. The main outcome measures were the Beck Depression Inventory-II (BDI-II) and the mobility domain of the Craig Handicap Assessment Reporting Technique-Short Form (CHARTSF). Results: Of the 190 participants, 49 (25.8%) had BDI-II scores (14+) indicative of depressive symptomatology. Sixty-nine (36.3%) were on antidepressants to treat depressive symptoms, and 31 (63.3%) of those with clinical symptoms of depression were on antidepressants. Participants with a history of depressive symptoms may be as high as 45.7% if both participants with BDI-II scores 14+ and those with antidepressant use specifically for the purposes of depression treatment are combined. In this population, lower CHART-SF mobility score, expressing "emotional concerns" as a reason for the visit on an intake sheet, and use of antidepressant medications were significantly associated with depressive symptoms. Conclusions: Depressive symptomatology appears to be common and undertreated in this cohort of adults with spina bifida, which may warrant screening for emotional concerns in routine clinic appointments. Significant depressive symptoms are associated with fewer hours out of bed and fewer days leaving the house. Additional research is needed to assess the impact of interventions directed toward mobility on depression and in the treatment of depression in this patient population.

AB - Objective: To examine the prevalence of depressive symptoms in adults with spina bifida and identify contributing factors for depressive symptomatology. Method: Retrospective Cohort Study. Data collection was conducted at a regional adult spina bifida clinic. A total of 190 charts from adult patients with spina bifida were included. The main outcome measures were the Beck Depression Inventory-II (BDI-II) and the mobility domain of the Craig Handicap Assessment Reporting Technique-Short Form (CHARTSF). Results: Of the 190 participants, 49 (25.8%) had BDI-II scores (14+) indicative of depressive symptomatology. Sixty-nine (36.3%) were on antidepressants to treat depressive symptoms, and 31 (63.3%) of those with clinical symptoms of depression were on antidepressants. Participants with a history of depressive symptoms may be as high as 45.7% if both participants with BDI-II scores 14+ and those with antidepressant use specifically for the purposes of depression treatment are combined. In this population, lower CHART-SF mobility score, expressing "emotional concerns" as a reason for the visit on an intake sheet, and use of antidepressant medications were significantly associated with depressive symptoms. Conclusions: Depressive symptomatology appears to be common and undertreated in this cohort of adults with spina bifida, which may warrant screening for emotional concerns in routine clinic appointments. Significant depressive symptoms are associated with fewer hours out of bed and fewer days leaving the house. Additional research is needed to assess the impact of interventions directed toward mobility on depression and in the treatment of depression in this patient population.

KW - Adult

KW - Depression

KW - Mobility

KW - Rehabilitation

KW - Spina bifida

UR - http://www.scopus.com/inward/record.url?scp=84941168585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941168585&partnerID=8YFLogxK

U2 - 10.1037/rep0000044

DO - 10.1037/rep0000044

M3 - Article

VL - 60

SP - 246

EP - 253

JO - Rehabilitation Psychology

T2 - Rehabilitation Psychology

JF - Rehabilitation Psychology

SN - 0090-5550

IS - 3

ER -